Data as at [XXX] IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
₹875.00-24.10 (-2.68%)
16:01 PM, 12-Mar-2025BSE : 530019
NSE : JUBLPHARMA
Sector : Health care
ISIN Code : INE700A01033
Last Updated: 12-Mar-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 13,939 |
Traded Value (₹ Cr) | 1.25 |
Volume (Shares) | 14,301 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,309.00 |
52-Week High Date | 07-Nov-2024 |
52-Week Low (₹) | 607.50 |
52-Week Low Date | 15-Apr-2024 |
All Time High (₹) | 1,309.00 |
All Time High Date | 07-Nov-2024 |
All Time Low (₹) | 3.05 |
All Time Low Date | 09-May-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 13,939 |
EPS - TTM (₹) [C] | 21.16 |
P/E Ratio (X) [C] | 41.35 |
Face Value (₹) | 1 |
Latest Dividend (%) | 500.00 |
Latest Dividend Date | 11-Aug-2022 |
Dividend Yield (%) | 0.58 |
Book Value Share (₹) [C] | 372.92 |
P/B Ratio (₹) [C] | 2.35 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Bandhan Small Cap Fund (G) | 60.30 | 6,68,027 | 0.71 |
Bandhan Small Cap Fund (IDCW) | 60.30 | 6,68,027 | 0.71 |
Bandhan Small Cap Fund - Direct (G) | 60.30 | 6,68,027 | 0.71 |
Bandhan Small Cap Fund - Direct (IDCW) | 60.30 | 6,68,027 | 0.71 |
Kotak Special Opportunities Fund - Direct (IDCW) | 40.62 | 4,50,000 | 2.18 |
Kotak Special Opportunities Fund - Direct (G) | 40.62 | 4,50,000 | 2.18 |
Kotak Special Opportunities Fund - Regular (IDCW) | 40.62 | 4,50,000 | 2.18 |
Kotak Special Opportunities Fund - Regular (G) | 40.62 | 4,50,000 | 2.18 |
Kotak MNC Fund - Regular (G) | 32.68 | 3,62,006 | 1.61 |
Kotak MNC Fund - Direct (IDCW) | 32.68 | 3,62,006 | 1.61 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
05-Mar-2025 | Edelweiss Research | Buy | 1,385 | |
07-Oct-2024 | Edelweiss Securities | Initiating Coverage | 1,450 |
Today's Low/High (₹) | 851.75 891.05 |
Week Low/High (₹) | 329.40 891.05 |
Month Low/High (₹) | 329.40 891.05 |
Year Low/High (₹) | 607.50 1,309.00 |
All time Low/High (₹) | 3.05 1,309.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 158.80% | 146.85% | 22.97% | 27.64% |
1 Month | 142.85% | 131.59% | 19.03% | 23.24% |
3 Month | 137.26% | 125.88% | 19.93% | 24.47% |
6 Month | 150.86% | 139.48% | 25.04% | 29.23% |
1 Year | 66.89% | 58.96% | 24.11% | 27.96% |
3 Year | 84.30% | 75.42% | 82.98% | 91.93% |
Chairman (Non-Executive) : Shyam S Bhartia
Co-Chairman & Managing Directo : Hari S Bhartia
Non-Exec. & Independent Dir. : S Sridhar
Non-Exec. & Independent Dir. : Sudha Pillai
Non-Exec. & Independent Dir. : Ashok Misra
Non-Exec. & Independent Dir. : Vivek Mehra
Non-Exec. & Independent Dir. : SUSHIL KUMAR ROONGTA
Non-Exec & Non-Independent Dir : Priyavrat Bhartia
Non-Exec & Non-Independent Dir : Arjun Shanker Bhartia
Non-Exec. & Independent Dir. : Arun Seth
Whole Time Director & CFO : Arvind Chokhany
Company Sec. & Compli. Officer : Naresh Kapoor
Whole Time Director : R Kumar
Registered Office: Bhartiagram Gajraula, ,Amroha,Uttar Pradesh-244223 Ph: 91-5924-267200
1. What's the Jubilant Pharmova Ltd share price today?
Jubilant Pharmova Ltd share price was Rs 875.00 at 16:01 PM IST on 12th Mar 2025. Jubilant Pharmova Ltd share price was down by 2.68% from the previous closing price of Rs 899.10. Jubilant Pharmova Ltd share price trend:
2. How can I quickly analyse the performance of the Jubilant Pharmova Ltd stock?
The performance of the Jubilant Pharmova Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd has a market capitalisation of Rs 13,939 crore.
4. What is Jubilant Pharmova Ltd's 52-week high/low share price?
The Jubilant Pharmova Ltd’s 52-week high share price is Rs 1,309.00 and 52-week low share price is Rs 607.50.
5. Is the Jubilant Pharmova Ltd profitable?
On a consolidated basis, Jubilant Pharmova Ltd reported a profit of Rs 100.70 crore on a total income of Rs 1,830.90 crore for the quarter ended 2024. For the year ended 2024, Jubilant Pharmova Ltd had posted a profit of Rs 72.70 crore on a total income of Rs 6,702.90 crore.
6. Which are Jubilant Pharmova Ltd’s peers in the Health care sector?
Jubilant Pharmova Ltd’s top 5 peers in the Health care sector are Neuland Labs., Caplin Point Lab, Natco Pharma, Jubilant Pharmo, Sanofi India, Alivus Life, Granules India.
7. Who owns how much in Jubilant Pharmova Ltd?
Key changes to the Jubilant Pharmova Ltd shareholding are as follows: